The DOI matches its Crossref record; 480 of the 482 references it cites were found in a registry or an index.
Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention
Open accessAbstract
Identification of cost-effective interventions to maintain muscle mass, muscle strength, and physical performance during muscle wasting and aging is an important public health challenge. It requires understanding of the cellular and molecular mechanisms involved. Muscle-deconditioning processes have been deciphered by means of several experimental models, bringing together the opportunities to devise comprehensive analysis of muscle wasting. Studies have increasingly recognized the importance of fatty infiltrations or intermuscular adipose tissue for the age-mediated loss of skeletal-muscle function and emphasized that this new important factor is closely linked to inactivity. The present review aims to address three main points. We first mainly focus on available experimental models involving cell, animal, or human experiments on muscle wasting. We next point out the role of intermuscular adipose tissue in muscle wasting and aging and try to highlight new findings concerning aging and muscle-resident mesenchymal stem cells called fibro/adipogenic progenitors by linking some cellular players implicated in both FAP fate modulation and advancing age. In the last part, we review the main data on the efficiency and molecular and cellular mechanisms by which exercise, replacement hormone therapies, and β-hydroxy-β-methylbutyrate prevent muscle wasting and sarcopenia. Finally, we will discuss a potential therapeutic target of sarcopenia: glucose 6-phosphate dehydrogenase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
Fico, A., Paglialunga, F., Cigliano, L., Abrescia, P., Verde, P., Martini, G., Iaccarino, I., & Filosa, S. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401420 · Cited by 147
RetractedSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Epidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 4×
“Muscle deconditioning occurring with aging is characterized by a decrease in muscle mass, in muscle strength, and in physical performance and is considered a geriatric syndrome called sarcopenia (Cruz-Jentoft et al., 2010; Fielding et al., 2011; Morley et al., 2011; Muscaritoli et al., 2010).”
BackgroundMethodInfluentialGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 1×
“…deterioration of the physical condition resulting in an increased risk of falls and fractures, a progressive inability to perform basic activities of daily living, loss of independence for the elderly, and ultimately, death (Cruz-Jentoft, 2012; Delmonico et al., 2007; Goodpaster et al., 2006).”
BackgroundThe Transforming Growth Factor-Beta Family
Massagué, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,041
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Flagged first, then by citations
2 of the 482 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Kimura, 2014, β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and FoxO1/3a phosphorylations and alleviates tumor necrosis factor α/interferon γ-induced MuRF-1 expression in C2C12 cells, Nutr. Res, 34, 368, 10.1016/j.nutres.2014.02.003 · DOI
- Lecker, 2004, Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression, FASEB J., 18, 39, 10.1096/fj.03-0610com · DOI · Paper page
Cited by
Sorted by citations
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Li, C., Yu, K., Shyh‐Chang, N., Jiang, Z., Liu, T., Ma, S., Luo, L., Guang, L., Liang, K., Ma, W., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12901 · Cited by 626
Imaging of sarcopenia: old evidence and new insights
Albano, D., Messina, C., Vitale, J. A., & Sconfienza, L. M. (2019) · European Radiology · doi:10.1007/s00330-019-06573-2 · Cited by 400
Epidemiology of sarcopenia and insight into possible therapeutic targets
Dennison, E. M., Sayer, A. A., & Cooper, C. C. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.60 · Cited by 302
Mouse models of sarcopenia: classification and evaluation
Xie, W., He, M., Yu, D., Wu, Y., Wang, X., Lv, S., Xiao, W., & Li, Y. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12709 · Cited by 240
Sarcopenia: imaging assessment and clinical application
Chianca, V., Albano, D., Messina, C., Gitto, S., Ruffo, G., Guarino, S., Grande, F. D., & Sconfienza, L. M. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03294-3 · Cited by 218
Metadata
- Authors
- Brioche, T., Pagano, A. F., Py, G., & Chopard, A.
- Affiliations
- Université de Montpellier (FR)
- Corresponding author
- Brioche, Thomas
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 50
- Issue
- 50
- Pages
- 56-87
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2344822791
- Cited by
- 129
- References
- 482
- Citations by year
- 2026: 10 · 2025: 9 · 2024: 17 · 2023: 8 · 2022: 19 · 2021: 17 · 2020: 18 · 2019: 8 · 2018: 14 · 2017: 8 · 2016: 1
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- green
- hal.science
- Licence
- Locations
- Molecular Aspects of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-sa)
- Funders
- Centre National d'Etudes Spatiales
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- muscle atrophy, sarcopenia, aging, intermuscular adipose tissue, fatty infiltration, muscle deconditioning, fibro-adipogenic progenitors, mesenchymal stem cells, physical activity, hormone replacement therapy, beta-hydroxy-beta-methylbutyrate, glucose-6-phosphate dehydrogenase, muscle mass and strength, physical performance
- MeSH terms
- Adipose Tissue, Aging, Animals, Glucosephosphate Dehydrogenase, Humans, Mitochondria, Models, Theoretical, Valerates, Weightlessness, Signal Transduction, Exercise, Apoptosis, Muscle, Skeletal, Dietary Supplements, Hormone Replacement Therapy, Models, Animal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
